ArticleFrontiers in psychology2022
Risk factors for worsening of somatic symptom burden in a prospective cohort during the COVID-19 pandemic.
Article in Frontiers in psychology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 33 citations in OpenAlex.
- Longitudinal evaluation of the psychometric stability of the somatic symptom scale-8 (SSS-8) in a large German general population sample.Scientific reports · 2026Article
- Somatisation Scores Associated With Healthcare Costs and Utilisation in a Sample of Emergency Department Patients.Emergency medicine Australasia : EMA · 2026Article
- Educating during the COVID-19 Pandemic: An Educator Perspective on Mental Health.Disaster medicine and public health preparedness · 2026Article
- Depression, but Not Fatigue, Improves as Part of Multimodal Post-COVID Rehabilitation.Psychotherapy and psychosomatics · 2026Article
- Psychometric evaluation and community norms of the Somatic Symptom Scale-8 based on a representative German sample.Frontiers in psychiatry · 2026Article
- Effectiveness of two interventions to optimize expectations in psychosomatic rehabilitation of post-COVID patients: study protocol for an integrative approach.Frontiers in psychiatry · 2026Article
- Excess of infection with SARS-CoV-2 during the first versus second wave of the COVID-19 pandemic among patients with long COVID.BMC public health · 2025Article
- Psychological and Social Factors Associated With Reporting Post-COVID Symptoms Among German Healthcare Workers: A Cross-Sectional Study.Journal of clinical nursing · 2025Article
- Psychometric Evaluation of Indonesian Version of the Somatic Symptom Scale-8 (ISSS-8).Journal of caring sciences · 2025Review
- Assessment of psychosocial aspects in adults in post-COVID-19 condition: the EURONET-SOMA recommendations on core outcome domains for clinical and research use.BMC medicine · 2025Review
- Development of an expectation management intervention for patients with Long COVID: A focus group study with affected patients.PloS one · 2025Article
- Internal medicine at the crossroads of long COVID diagnosis and management.Frontiers in medicine · 2025Review
- Neurological, psychological, psychosocial complications of long-COVID and their management.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025Review
- Review
- Psychological burden associated with incident persistent symptoms and their evolution during the COVID-19 pandemic: a prospective population-based study.BMJ mental health · 2024Article
- Psychological risk factors for Long COVID and their modification: study protocol of a three-arm, randomised controlled trial (SOMA.COV).BJPsych open · 2023Article
- Article
- Depression and anxiety before and at the beginning of the COVID-19 pandemic and incident persistent symptoms: a prospective population-based cohort study.Molecular psychiatry · 2023Article
- Long-term effects of SARS-CoV-2 infection on human brain and memory.Cell death discovery · 2023Review
- [Role of psychological factors in post-COVID-19 condition].Bulletin de l'Academie nationale de medecine · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Little is known about risk factors for both Long COVID and somatic symptoms that develop in individuals without a history of COVID-19 in response to the pandemic. There is reason to assume an interplay between pathophysiological mechanisms and psychosocial factors in the etiology of symptom persistence. Objective: Therefore, this study investigates specific risk factors for somatic symptom deterioration in a cohort of German adults with and without prior SARS-CoV-2 infection. Methods: German healthcare professionals underwent SARS-CoV-2 IgG antibody testing and completed self-rating questionnaires at baseline and 21 months later between April 2020 and February 2022. Differences in variables between the time points were analyzed and a regression analysis was performed to predict somatic symptom deterioration at follow-up. Results: Seven hundred fifty-one adults completed both assessments. Until follow-up, Conclusions: This study supports a disease-overarching biopsychosocial model for the development of burdensome somatic symptoms during the COVID-19 pandemic and supports research findings that symptom burden may be more related to the psychosocial effects of the pandemic than to infection itself. Future studies on Long COVID should include SARS-CoV-2 negative control groups and consider symptom burden prior to infection in order to avoid an overestimation of prevalence rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.